Find Nystatin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

285RELATED EXCIPIENT COMPANIES

465EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Nystatin, 34786-70-4, W1lx4t91wi, Nystatinum, Terrastatin, Nyotran
Molecular Formula
C47H75NO17
Molecular Weight
926.1  g/mol
InChI Key
VQOXZBDYSJBXMA-NQTDYLQESA-N
FDA UNII
W1LX4T91WI

Nystatin
Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.
1 2D Structure

Nystatin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,3R,4R,7R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
2.1.2 InChI
InChI=1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33+,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1
2.1.3 InChI Key
VQOXZBDYSJBXMA-NQTDYLQESA-N
2.1.4 Canonical SMILES
CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
2.1.5 Isomeric SMILES
C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
2.2 Other Identifiers
2.2.1 UNII
W1LX4T91WI
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Fungicidin

2. Mycostatin

3. Nilstat

4. Nystatin

5. Nystatin A2

6. Nystatin A3

7. Nystatin G

8. Stamicin

9. Stamycin

2.3.2 Depositor-Supplied Synonyms

1. Nystatin

2. 34786-70-4

3. W1lx4t91wi

4. Nystatinum

5. Terrastatin

6. Nyotran

7. (1s,3r,4r,7r,9r,11r,15s,16r,17r,18s,19e,21e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic Acid

8. Mikostatin

9. L-nystatin

10. Unii-w1lx4t91wi

11. Nystatin A1 [mi]

12. Chembl450895

13. Schembl18633553

14. Dtxsid80872323

15. Chebi:473992

16. Lmpk06000004

17. Akos032963569

18. Zinc253387941

19. Q27292191

20. (7r,10r)-8,9-dideoxy-28,29-dihydro-7,10-dihydroxyamphotericin B

21. (1s,3r,4e,6e,8e,10e,14e,16e,18s,19r,20r,21s,25r,27r,29r,32r,33r,35s,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic Acid

22. (1s,3r,4r,7r,9r,11r,15s,16r,17r,18s,19e,21e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(3-amino-3,6-dideoxy-beta-d-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic Acid

23. (1s,3r,4r,7r,9r,11r,15s,16r,17r,18s,19e,21z,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic Acid

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 926.1 g/mol
Molecular Formula C47H75NO17
XLogP3-0.2
Hydrogen Bond Donor Count12
Hydrogen Bond Acceptor Count18
Rotatable Bond Count3
Exact Mass925.50349992 g/mol
Monoisotopic Mass925.50349992 g/mol
Topological Polar Surface Area320 Ų
Heavy Atom Count65
Formal Charge0
Complexity1620
Isotope Atom Count0
Defined Atom Stereocenter Count19
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count6
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Antibiotics, Antifungal; Antibiotics, Macrolide; Ionophores

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


MEDICATION (VET):Antifungal; growth promotant

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1208


MEDICATION (VET): /Used in treatment of/ intestinal mycosis due to Candida albicans in poultry; occasionally orally in cats and dogs in suspected Candida intestinal overgrowth following antibiotic therapy, and also topically ... as cream or ointment on skin lesions ...

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 397


Nystatin vaginal tablets are used as lozenges to treat oropharyngeal candidiasis since their slow dissolution rate provides prolonged oral contact. /NOT included in US product labeling/

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2226


For more Therapeutic Uses (Complete) data for NYSTATIN (9 total), please visit the HSDB record page.


4.2 Drug Warning

Since it is not known whether nystatin is distributed into human milk, the drug should be used with caution in nursing women.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 543


Adverse effects occur infrequently with oral nystatin therapy. Mild and transitory nausea, vomiting, GI distress, and diarrhea have occurred; high oral doses (e.g., greater than 5 million units daily) are most likely to produce these adverse GI effects. Hypersensitivity reactions have been reported very rarely.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 543


Patients should be instructed to contact their physician if symptoms of irritation or sensitization occur during nystatin therapy. Patients should be warned against interrupting or discontinuing vaginal nystatin therapy during a prescribed regimen, even during menstruation or if symptomatic relief occurs after only a few days of therapy, unless otherwise instructed by their physician. Patients should be advised that adjunctive measures such as therapeutic douches are not necessary and may be inadvisable during vaginal nystatin therapy; however, cleansing douches may be used in nonpregnant women, if desired, for aesthetic effect.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3432


Adverse reactions to topically applied nystatin are very infrequent, even during prolonged use. Irritation has occurred rarely. Hypersensitivity reactions to nystatin have been reported only rarely; however, preservatives (eg, ethylenediamine, parabens, thimerosal) in some of the formulations are associated with a high incidence of contact dermatitis. An acneiform eruption has occurred rarely following topical application of nystatin and triamcinolone acetonide.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3432


For more Drug Warnings (Complete) data for NYSTATIN (9 total), please visit the HSDB record page.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Antifungal Agents

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)


Ionophores

Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. (See all compounds classified as Ionophores.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Polyenes [CS]; Polyene Antifungal [EPC]
5.3 ATC Code

A - Alimentary tract and metabolism

A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents

A07A - Intestinal antiinfectives

A07AA - Antibiotics

A07AA02 - Nystatin


D - Dermatologicals

D01 - Antifungals for dermatological use

D01A - Antifungals for topical use

D01AA - Antibiotics

D01AA01 - Nystatin


G - Genito urinary system and sex hormones

G01 - Gynecological antiinfectives and antiseptics

G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids

G01AA - Antibiotics

G01AA01 - Nystatin


5.4 Absorption, Distribution and Excretion

Nystatin penetrates eye poorly.

American Medical Association, AMA Department of Drugs, AMA Drug Evaluations. 3rd ed. Littleton, Massachusetts: PSG Publishing Co., Inc., 1977., p. 969


Nystatin is poorly absorbed from the GI tract, and detectable blood concentrations are not obtained after usual doses. Following oral administration, nystatin is excreted almost entirely in feces as unchanged drug.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 543


In healthy individuals, mean salivary nystatin concentrations in excess of those required in vitro for growth inhibition of clinically important Candida persist for approximately 2 hours after the beginning of oral dissolution of two nystatin lozenges (400,000 units) administered simultaneously.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 3432


Not absorbed following topical application to intact skin or mucous membranes.

Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 2225


For more Absorption, Distribution and Excretion (Complete) data for NYSTATIN (6 total), please visit the HSDB record page.


5.5 Mechanism of Action

Nystatin exerts its antifungal activity by binding to sterols in the fungal cell membrane. The drug is not active against organisms (e.g., bacteria) that do not contain sterols in their cell membrane. As a result of this binding, the membrane is no longer able to function as a selective barrier, and potassium and other cellular constituents are lost.

McEvoy, G.K. (ed.). American Hospital Formulary Service. AHFS Drug Information. American Society of Health-System Pharmacists, Bethesda, MD. 2006., p. 543


... /Antimicrobial/ agents that act directly on the cell membrane of the microorganism, affecting permeability and leading to leakage of intracellular compounds; these include ... the polyene antifungal agents nystatin ... which bind to cell-wall sterols ...

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1143


CEP/COS

read-more
read-moreread-more

01

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Certificate Number : R1-CEP 2003-096 - Rev 04

Status : Valid

Issue Date : 2022-01-28

Type : Chemical

Substance Number : 517

blank

03

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Certificate Number : R0-CEP 2020-247 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2022-10-12

Type : Chemical

Substance Number : 517

blank

04

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

Certificate Number : CEP 2003-118 - Rev 08

Status : Valid

Issue Date : 2025-12-16

Type : Chemical

Substance Number : 517

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Nystatin

About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...

Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Shanghai Minbiotech CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Flag India
Digital Content Digital Content

Nystatin

About the Company : Fishfa Biogenics, a division of Fishfa Rubbers Ltd., manufactures and supplies biological APIs. The company operates GLP labs and WHO-GMP-certified facilities, specializing in ferm...

Fishfa Biogenics, a division of Fishfa Rubbers Ltd., manufactures and supplies biological APIs. The company operates GLP labs and WHO-GMP-certified facilities, specializing in fermentation-based production, process development, and manufacturing. Its site includes microbial drug substance production, quality testing, and technical, regulatory, and IP support. Fishfa exports APIs such as Mupirocin and Tacrolimus to markets in Europe, Asia, the Middle East, South America, Russia, New Zealand, and the UK. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Fishfa Biogenics

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.

Flag India
Digital Content Digital Content

Nystatin

About the Company : Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs a...

Cerata Pharmaceuticals LLP is a WHO-GMP certified pharmaceutical API manufacturer based in Gujarat, India. We specialize in the development and manufacturing of high-quality APIs and High Potency APIs, adhering to the highest global quality and compliance standards. As a fully integrated company, Cerata supports the complete API lifecycle from development to commercialization. Our products are trusted by pharmaceutical companies in over 40 countries, reflecting our strong global presence and commitment to excellence. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

04

Antibiotice

Romania
AMWC Asia-TDAC
Not Confirmed
arrow

Antibiotice

Romania
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 13...

Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 137 drug portfolio covers a wide range of therapeutic areas, product development strategy is focused today on cardiovascular medication class, anti-infective and system CNS. domestic Antibiotics differentiates the main producer of anti-infective drugs and the only manufacturer of active substances obtained by biosynthesis (Nystatin).
blank

05

Antibiotice

Romania
AMWC Asia-TDAC
Not Confirmed
arrow

Antibiotice

Romania
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 13...

Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 137 drug portfolio covers a wide range of therapeutic areas, product development strategy is focused today on cardiovascular medication class, anti-infective and system CNS. domestic Antibiotics differentiates the main producer of anti-infective drugs and the only manufacturer of active substances obtained by biosynthesis (Nystatin).
blank

06

Antibiotice

Romania
AMWC Asia-TDAC
Not Confirmed
arrow

Antibiotice

Romania
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 13...

Antibiotice is the most important Romanian producer of generic drugs.Antibiotics mission is to transform valuable treatments in a more accessible way to improve people's lives. 137 drug portfolio covers a wide range of therapeutic areas, product development strategy is focused today on cardiovascular medication class, anti-infective and system CNS. domestic Antibiotics differentiates the main producer of anti-infective drugs and the only manufacturer of active substances obtained by biosynthesis (Nystatin).
blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...

BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.
blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Established in 1869, Centrient Pharmaceuticals is a global B2B pharmaceutical company focused on sustainable, enzymatic antibiotics, next-generation statins, and antifungals. The c...

Established in 1869, Centrient Pharmaceuticals is a global B2B pharmaceutical company focused on sustainable, enzymatic antibiotics, next-generation statins, and antifungals. The company manufactures and markets intermediates, Active Pharmaceutical Ingredients (APIs), and finished dosage forms such as tablets and capsules. Centrient is driven by a purpose to improve lives through innovative and sustainable manufacturing, with a strong commitment to quality, reliability, and long-term partnerships with generics marketers. Note:Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Fujian Fukang Pharmaceutical Co., Ltd (Fukang) is located in Fuzhou-capital of Fujian province, founded in 1958, renamed Fuzhou Antibiotic General Factory in 1992 and became a whol...

Fujian Fukang Pharmaceutical Co., Ltd (Fukang) is located in Fuzhou-capital of Fujian province, founded in 1958, renamed Fuzhou Antibiotic General Factory in 1992 and became a wholly state-owned enterprise in 1996. In 2002 it was reformed into a corporation with a variety of shareholders. Over more than 40 years Fukang is steadily growing. Starting from a single product, its current product range includes 7ACA intermediate, sterile cephalosporin API, antibiotic API, preparation and Animal Feed. As one of the top 100 pharmaceutical enterprises in China in terms of sales volume and profit.
blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Nystatin

Brand Name : Mycostatin

Dosage Form : Oral Suspension

Dosage Strength : 100000IU

Packaging :

Approval Date : 18/05/1967

Application Number : 33043

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

02

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : PRESCRIPTION

Registration Country : Canada

NYSTATIN

Brand Name : FLAGYSTATIN

Dosage Form : OVULE

Dosage Strength : 100000UNIT

Packaging : 10

Approval Date :

Application Number : 1926829

Regulatory Info : PRESCRIPTION

Registration Country : Canada

Sanofi Company Banner

03

Nystatin

Brand Name : Canstat Topical

Dosage Form : CRE

Dosage Strength : 100000u/g

Packaging : 15X1u/g

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

04

Nystatin

Brand Name : Nystacid

Dosage Form : OIN

Dosage Strength : 100000u/g

Packaging : 15X1u/g

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

05

Nystatin

Brand Name : Canstat Vaginal Tablets 100 000 U/Tablet

Dosage Form : VAT

Dosage Strength : 100000u

Packaging : 15X1u

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

06

Nystatin

Brand Name : Canstat Suspension

Dosage Form : SUS

Dosage Strength : 100000u/ml

Packaging : 20X1u/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

07

Nystatin

Brand Name : Nystacid Oral Suspension

Dosage Form : SUS

Dosage Strength : 100000u/ml

Packaging : 20X1u/ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

08

Nystatin

Brand Name : Mycostatin Oral Drops

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Aspen API Comapny Banner

09

Nystatin

Brand Name : Nilstat

Dosage Form :

Dosage Strength :

Packaging : 50

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Aspen API Comapny Banner

10

Nystatin

Brand Name : Nilstat

Dosage Form :

Dosage Strength :

Packaging : 50

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Aspen API Comapny Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AT

NYSTATIN

Brand Name : NYSTATIN

Dosage Form : POWDER;TOPICAL

Dosage Strength : 100,000 UNITS/GM

Approval Date : 2004-07-15

Application Number : 65203

RX/OTC/DISCN : RX

RLD : No

TE Code : AT

Dr Reddy Company Banner

02

DR REDDYS

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AT

NYSTATIN; TRIAMCINOLONE ACETONIDE

Brand Name : NYSTATIN AND TRIAMCINOLONE ACETONIDE

Dosage Form : OINTMENT;TOPICAL

Dosage Strength : 100,000 UNITS/GM;0.1%

Approval Date : 2017-01-31

Application Number : 207741

RX/OTC/DISCN : RX

RLD : No

TE Code : AT

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : Yes

TE Code :

NYSTATIN

Brand Name : NILSTAT

Dosage Form : POWDER;ORAL

Dosage Strength : 100% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1983-12-22

Application Number : 50576

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

NYSTATIN; TRIAMCINOLONE ACETONIDE

Brand Name : NYSTATIN AND TRIAMCINOLONE ACETONIDE

Dosage Form : OINTMENT;TOPICAL

Dosage Strength : 100,000 UNITS/GM;0.1%

Approval Date : 2018-01-29

Application Number : 210077

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

05

COSETTE

U.S.A
AMWC Asia-TDAC
Not Confirmed
arrow

COSETTE

U.S.A
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN

Brand Name : NYSTATIN

Dosage Form : CREAM;TOPICAL

Dosage Strength : 100,000 UNITS/GM

Approval Date : 1982-01-01

Application Number : 61966

RX/OTC/DISCN : RX

RLD : No

TE Code : AT

blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN

Brand Name : MYCOSTATIN

Dosage Form : POWDER;TOPICAL

Dosage Strength : 100,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 60578

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

07

FOUGERA

U.S.A
AMWC Asia-TDAC
Not Confirmed
arrow

FOUGERA

U.S.A
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN

Brand Name : NYSTATIN

Dosage Form : TABLET;VAGINAL

Dosage Strength : 100,000 UNITS

Approval Date : 1983-11-09

Application Number : 62459

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN; TRIAMCINOLONE ACETONIDE

Brand Name : NYSTATIN AND TRIAMCINOLONE ACETONIDE

Dosage Form : OINTMENT;TOPICAL

Dosage Strength : 100,000 UNITS/GM;0.1%

Approval Date : 1985-10-10

Application Number : 62280

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

09

RISING

U.S.A
AMWC Asia-TDAC
Not Confirmed
arrow

RISING

U.S.A
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN; TRIAMCINOLONE ACETONIDE

Brand Name : NYSTATIN AND TRIAMCINOLONE ACETONIDE

Dosage Form : OINTMENT;TOPICAL

Dosage Strength : 100,000 UNITS/GM;0.1%

Approval Date : 2016-12-29

Application Number : 206785

RX/OTC/DISCN : RX

RLD : No

TE Code : AT

blank

10

TARO

U.S.A
AMWC Asia-TDAC
Not Confirmed
arrow

TARO

U.S.A
arrow
AMWC Asia-TDAC
Not Confirmed

NYSTATIN

Brand Name : NYSTATIN

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 100,000 UNITS/ML

Approval Date : 1988-02-29

Application Number : 62876

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Nystatin

Brand Name : Mycostatin

Dosage Form : Oral Suspension

Dosage Strength : 100000IU

Packaging :

Approval Date : 18/05/1967

Application Number : 33043

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

02

2Care4 Aps

Denmark
AMWC Asia-TDAC
Not Confirmed
arrow

2Care4 Aps

Denmark
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Nystimex

Dosage Form : Oral Suspension

Dosage Strength : 100;000IU/ml

Packaging :

Approval Date : 09-09-2019

Application Number : 28106266519

Regulatory Info : Prescription

Registration Country : Denmark

blank

03

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Nystatin Abacus Medicine

Dosage Form : Oral Suspension

Dosage Strength : 100000IU/ml

Packaging :

Approval Date : 22-11-2022

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

04

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Nystatin Atb®

Dosage Form : Vaginal Suppositories

Dosage Strength : 100000IU

Packaging :

Approval Date : 26-08-2021

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin; Triamcinolone Acetonide

Brand Name : Assocort

Dosage Form :

Dosage Strength : Ung Derm 30 G  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin; Triamcinolone Acetonide

Brand Name : Kenacombin Novum

Dosage Form : Cream

Dosage Strength :

Packaging :

Approval Date : 17-05-1995

Application Number : 2.00E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

07

Dermapharm Ag

Germany
AMWC Asia-TDAC
Not Confirmed
arrow

Dermapharm Ag

Germany
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Multilind

Dosage Form : Oral Suspension

Dosage Strength : 100000IU

Packaging :

Approval Date : 08/11/2005

Application Number : 57263

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Triamcinolone Acetonide; Nystatin; Neomycin Sulfate

Brand Name : Positon

Dosage Form : Cream

Dosage Strength : 2.5MG; 1MG; 100,000MG

Packaging :

Approval Date : 01-02-1970

Application Number : 48825

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Orifarm AS

Denmark
AMWC Asia-TDAC
Not Confirmed
arrow

Orifarm AS

Denmark
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Mycostatin

Dosage Form : Oral Suspension

Dosage Strength : 100000IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

Nystatin

Brand Name : Mycostatin

Dosage Form : Oral Suspension

Dosage Strength : 100;000IU/ml

Packaging :

Approval Date : 02-01-1992

Application Number : 28101460791

Regulatory Info : Prescription

Registration Country : Denmark

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Taste Masking

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Empty Capsules

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 1400-61-9 / Nystatin API manufacturers, exporters & distributors?

Nystatin manufacturers, exporters & distributors 1

78

PharmaCompass offers a list of Nystatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nystatin manufacturer or Nystatin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nystatin manufacturer or Nystatin supplier.

API | Excipient name

Nystatin

Synonyms

34786-70-4, W1lx4t91wi, Nystatinum, Terrastatin, Nyotran, (1s,3r,4r,7r,9r,11r,15s,16r,17r,18s,19e,21e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid

Cas Number

1400-61-9

Unique Ingredient Identifier (UNII)

W1LX4T91WI

About Nystatin

Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.

MYTREX F Manufacturers

A MYTREX F manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MYTREX F, including repackagers and relabelers. The FDA regulates MYTREX F manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MYTREX F API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MYTREX F manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

MYTREX F Suppliers

A MYTREX F supplier is an individual or a company that provides MYTREX F active pharmaceutical ingredient (API) or MYTREX F finished formulations upon request. The MYTREX F suppliers may include MYTREX F API manufacturers, exporters, distributors and traders.

click here to find a list of MYTREX F suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

MYTREX F USDMF

A MYTREX F DMF (Drug Master File) is a document detailing the whole manufacturing process of MYTREX F active pharmaceutical ingredient (API) in detail. Different forms of MYTREX F DMFs exist exist since differing nations have different regulations, such as MYTREX F USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A MYTREX F DMF submitted to regulatory agencies in the US is known as a USDMF. MYTREX F USDMF includes data on MYTREX F's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MYTREX F USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of MYTREX F suppliers with USDMF on PharmaCompass.

MYTREX F CEP

A MYTREX F CEP of the European Pharmacopoeia monograph is often referred to as a MYTREX F Certificate of Suitability (COS). The purpose of a MYTREX F CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MYTREX F EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MYTREX F to their clients by showing that a MYTREX F CEP has been issued for it. The manufacturer submits a MYTREX F CEP (COS) as part of the market authorization procedure, and it takes on the role of a MYTREX F CEP holder for the record. Additionally, the data presented in the MYTREX F CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MYTREX F DMF.

A MYTREX F CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MYTREX F CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MYTREX F suppliers with CEP (COS) on PharmaCompass.

MYTREX F WC

A MYTREX F written confirmation (MYTREX F WC) is an official document issued by a regulatory agency to a MYTREX F manufacturer, verifying that the manufacturing facility of a MYTREX F active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MYTREX F APIs or MYTREX F finished pharmaceutical products to another nation, regulatory agencies frequently require a MYTREX F WC (written confirmation) as part of the regulatory process.

click here to find a list of MYTREX F suppliers with Written Confirmation (WC) on PharmaCompass.

MYTREX F NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MYTREX F as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for MYTREX F API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture MYTREX F as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain MYTREX F and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MYTREX F NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of MYTREX F suppliers with NDC on PharmaCompass.

MYTREX F GMP

MYTREX F Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of MYTREX F GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right MYTREX F GMP manufacturer or MYTREX F GMP API supplier for your needs.

MYTREX F CoA

A MYTREX F CoA (Certificate of Analysis) is a formal document that attests to MYTREX F's compliance with MYTREX F specifications and serves as a tool for batch-level quality control.

MYTREX F CoA mostly includes findings from lab analyses of a specific batch. For each MYTREX F CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

MYTREX F may be tested according to a variety of international standards, such as European Pharmacopoeia (MYTREX F EP), MYTREX F JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MYTREX F USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty